HUIZE HOLDING LTD-ADR (HUIZ)

US44473E1055 - ADR

0.615  -0.02 (-3.53%)

After market: 0.615 0 (0%)

Fundamental Rating

5

Taking everything into account, HUIZ scores 5 out of 10 in our fundamental rating. HUIZ was compared to 141 industry peers in the Insurance industry. While HUIZ has a great health rating, its profitability is only average at the moment. HUIZ is not valued too expensively and it also shows a decent growth rate.



4

1. Profitability

1.1 Basic Checks

HUIZ had positive earnings in the past year.
HUIZ had negative earnings in 4 of the past 5 years.
In multiple years HUIZ reported negative operating cash flow during the last 5 years.

1.2 Ratios

HUIZ has a Return On Assets of 7.41%. This is amongst the best in the industry. HUIZ outperforms 92.81% of its industry peers.
HUIZ's Return On Equity of 17.32% is fine compared to the rest of the industry. HUIZ outperforms 76.98% of its industry peers.
HUIZ has a Return On Invested Capital of 7.30%. This is amongst the best in the industry. HUIZ outperforms 90.65% of its industry peers.
Industry RankSector Rank
ROA 7.41%
ROE 17.32%
ROIC 7.3%
ROA(3y)-0.42%
ROA(5y)-1.57%
ROE(3y)-7.25%
ROE(5y)-8.74%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HUIZ has a Profit Margin (5.87%) which is comparable to the rest of the industry.
HUIZ has a Operating Margin of 4.27%. This is in the lower half of the industry: HUIZ underperforms 64.75% of its industry peers.
In the last couple of years the Operating Margin of HUIZ has declined.
The Gross Margin of HUIZ (37.35%) is better than 93.53% of its industry peers.
HUIZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.27%
PM (TTM) 5.87%
GM 37.35%
OM growth 3YN/A
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.11%
GM growth 5Y-0.05%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HUIZ is creating some value.
The number of shares outstanding for HUIZ has been reduced compared to 1 year ago.
HUIZ has less shares outstanding than it did 5 years ago.
HUIZ has a better debt/assets ratio than last year.

2.2 Solvency

HUIZ has an Altman-Z score of 1.29. This is a bad value and indicates that HUIZ is not financially healthy and even has some risk of bankruptcy.
HUIZ has a Altman-Z score of 1.29. This is amongst the best in the industry. HUIZ outperforms 87.05% of its industry peers.
HUIZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC1.18
WACC6.16%

2.3 Liquidity

HUIZ has a Current Ratio of 1.53. This is a normal value and indicates that HUIZ is financially healthy and should not expect problems in meeting its short term obligations.
HUIZ has a better Current ratio (1.53) than 89.93% of its industry peers.
A Quick Ratio of 1.53 indicates that HUIZ should not have too much problems paying its short term obligations.
HUIZ has a Quick ratio of 1.53. This is amongst the best in the industry. HUIZ outperforms 89.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 327.13% over the past year.
The Revenue has been growing slightly by 3.25% in the past year.
The Revenue has been growing by 18.63% on average over the past years. This is quite good.
EPS 1Y (TTM)327.13%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q81.4%
Revenue 1Y (TTM)3.25%
Revenue growth 3Y-0.68%
Revenue growth 5Y18.63%
Revenue growth Q2Q-8.67%

3.2 Future

Based on estimates for the next years, HUIZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.41% on average per year.
The Revenue is expected to decrease by -2.93% on average over the next years.
EPS Next Y8.82%
EPS Next 2Y19.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.94%
Revenue Next 2Y-2.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.42 indicates a rather cheap valuation of HUIZ.
Based on the Price/Earnings ratio, HUIZ is valued cheaper than 84.17% of the companies in the same industry.
HUIZ is valuated cheaply when we compare the Price/Earnings ratio to 25.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 3.77 indicates a rather cheap valuation of HUIZ.
84.17% of the companies in the same industry are more expensive than HUIZ, based on the Price/Forward Earnings ratio.
HUIZ's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.63.
Industry RankSector Rank
PE 3.42
Fwd PE 3.77

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HUIZ's earnings are expected to grow with 19.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y19.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HUIZ!.
Industry RankSector Rank
Dividend Yield N/A

HUIZE HOLDING LTD-ADR

NASDAQ:HUIZ (4/25/2024, 7:00:01 PM)

After market: 0.615 0 (0%)

0.615

-0.02 (-3.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap31.47M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 3.42
Fwd PE 3.77
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.41%
ROE 17.32%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.27%
PM (TTM) 5.87%
GM 37.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)327.13%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y8.82%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.25%
Revenue growth 3Y-0.68%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y